- Home
- CPF vs CRMD Comparison
CPF vs CRMD Comparison
Compare CPF & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPF
- CRMD
- Stock Information
- Founded
- CPF 1954
- CRMD 2006
- Country
- CPF United States
- CRMD United States
- Employees
- CPF N/A
- CRMD N/A
- Industry
- CPF Major Banks
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- CPF Finance
- CRMD Health Care
- Exchange
- CPF Nasdaq
- CRMD Nasdaq
- Market Cap
- CPF 717.2M
- CRMD 576.4M
- IPO Year
- CPF N/A
- CRMD 2010
- Fundamental
- Price
- CPF $28.38
- CRMD $11.52
- Analyst Decision
- CPF Buy
- CRMD Strong Buy
- Analyst Count
- CPF 1
- CRMD 6
- Target Price
- CPF $30.00
- CRMD $15.67
- AVG Volume (30 Days)
- CPF 286.0K
- CRMD 1.2M
- Earning Date
- CPF 01-29-2025
- CRMD 10-30-2024
- Dividend Yield
- CPF 3.79%
- CRMD N/A
- EPS Growth
- CPF N/A
- CRMD N/A
- EPS
- CPF 2.10
- CRMD N/A
- Revenue
- CPF $244,643,000.00
- CRMD $12,262,234.00
- Revenue This Year
- CPF N/A
- CRMD N/A
- Revenue Next Year
- CPF $7.80
- CRMD $300.00
- P/E Ratio
- CPF $13.06
- CRMD N/A
- Revenue Growth
- CPF N/A
- CRMD 41184.20
- 52 Week Low
- CPF $18.00
- CRMD $2.89
- 52 Week High
- CPF $33.25
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- CPF 49.23
- CRMD 67.84
- Support Level
- CPF $26.00
- CRMD $7.91
- Resistance Level
- CPF $28.04
- CRMD $11.50
- Average True Range (ATR)
- CPF 0.81
- CRMD 0.53
- MACD
- CPF 0.02
- CRMD 0.39
- Stochastic Oscillator
- CPF 81.19
- CRMD 90.30
About CPF Central Pacific Financial Corp New
Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.